Insulin-degrading enzyme(IDE) and enkephalinase(NEP) have strong ability to degrade insulin and Aβ42, which are associated with neurodegeneration in Alzheimer’s disease (132). Here, IDE is linked to early-onset autosomal dominant Alzheimer disease.